The legacy of Sildenafil offers a intricate case study for stakeholders eyeing pharma. While early sales were explosive, present patent lapse and the rise of generic versions have severely influenced profitability. In https://blanchevioi199906.frewwebs.com/40121196/sildenafil-and-big-pharma-a-dangerous-investment